» Articles » PMID: 30603273

Antihypertensive and Metabolic Effects of Hydrochlorothiazide Versus Amlodipine when Added to Losartan in Patients with Type 2 Diabetes

Overview
Journal Diabetol Int
Specialty Endocrinology
Date 2019 Jan 4
PMID 30603273
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

We performed a prospective, randomized, multicenter, parallel-group, per-protocol study to compare the effects of hydrochlorothiazide (HCTZ) and amlodipine as add-on to losartan treatment in hypertensive type 2 diabetic patients. A total of 49 Japanese type 2 diabetic patients with inadequate control of blood pressure while receiving losartan 50 mg were randomly allocated to receive a fixed-dose single-pill combination of HCTZ 12.5 mg plus losartan ( = 26) or a free combination of amlodipine 5 mg plus losartan ( = 23). During 8 weeks of follow-up, changes in blood pressure and laboratory data including HbA1c, uric acid, and potassium were compared between the groups using analysis of covariance. Systolic and diastolic blood pressure decreased in both groups, the reductions of which were greater in the amlodipine group. However, the least square mean (95 % CI) differences between groups were not statistically significant [2.3 (-6.8 to 11.4) mmHg,  = 0.618 and 2.7 (-2.4-7.9) mmHg,  = 0.293, respectively]. HbA1c increased in patients receiving HCTZ but not in the amlodipine group. Uric acid also increased in patients receiving HCTZ but decreased in patients receiving amlodipine, yielding a significant between-group difference of 1.0 (0.5-1.5) mg/dl ( < 0.001). No intra- or intergroup change was observed in serum potassium levels. This pilot study suggests that HCTZ and amlodipine result in nonsignificant effects on systolic and diastolic blood pressure reduction when administrated as add-on therapy to losartan in hypertensive patients with type 2 diabetes; however, addition of HCTZ may be associated with less favorable effects on metabolic profiles than amlodipine.

Citing Articles

Amlodipine Vs. hydrochlorothiazide: is there any disparity in its antihypertensive effect or not?.

Jonnalagadda V, Choudhary K, Matety V Clin Hypertens. 2017; 23:27.

PMID: 29234523 PMC: 5719742. DOI: 10.1186/s40885-017-0082-0.

References
1.
. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group. JAMA. 2000; 283(15):1967-75. View

2.
Franse L, Pahor M, Di Bari M, Shorr R, Wan J, Somes G . Serum uric acid, diuretic treatment and risk of cardiovascular events in the Systolic Hypertension in the Elderly Program (SHEP). J Hypertens. 2000; 18(8):1149-54. DOI: 10.1097/00004872-200018080-00021. View

3.
RUNYAN Jr J . Influence of thiazide diuretics on carbohydrate metabolism in patients with mild diabetes. N Engl J Med. 1962; 267:541-3. DOI: 10.1056/NEJM196209132671105. View

4.
Dahlof B, Sever P, Poulter N, Wedel H, Beevers D, Caulfield M . Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm.... Lancet. 2005; 366(9489):895-906. DOI: 10.1016/S0140-6736(05)67185-1. View

5.
Zillich A, Garg J, Basu S, Bakris G, Carter B . Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension. 2006; 48(2):219-24. DOI: 10.1161/01.HYP.0000231552.10054.aa. View